Heterocyclic Building Blocks-isoxazole

β-Aminovinyl ketones. II. Some reactions of alkyl 2-dialkylaminovinyl ketones was written by Kochetkov, N. K.. And the article was included in Izvestiya Akademii Nauk SSSR, Seriya Khimicheskaya in 1954.Safety of 5-Methylisoxazole This article mentions the following:

AcCH:CHNEt₂ (I) (5 g.) in 40 ml. EtOH hydrogenated over 0.15 g. PtO₂ 11 hrs. at room temperature absorbed only 750 ml. H; distillation gave 2.1 g. original I, along with a fraction, b. below 85°; acidification of the latter with HCl and redistillation gave a distillate in which AcEt was detected, while the distillation residue contained Et₂NH.HCl. Thus ketones of this type are hydrogenolyzed readily. Heating 14 g. I and 7.5 g. NH₂OH.HCl in 40 ml. MeOH 5 hrs., then adding 70 g. CdCl₂ in 50 ml. H₂O gave a crop of crystals, which were separated, moistened with a little H₂O, and subjected to dry distillation, yielding 59% 5-methylisoxazole, b₇₅₀ 121-2°, d₂₀ 1.0224, n_D²⁰ 1.4368; this treated with EtONa in EtOH, then with Et₂O, gave a precipitate of Na salt of AcCH₂CN, corresponding to 92% yield; this readily gave MeC(:NNPh)CH₂CN, m. 100-1°. Heating 13 g. PrCOCH:CHNMe₂ with 7.5 g. NH₂OH.HCl in MeOH as above 5 hrs., adding 3 volumes H₂O, and extracting with Et₂O gave 89% 5-propylisoxazole, b. 161-1.5°, d₂₀ 0.9682, n_D²⁰ 1.4460; with EtONa-EtOH this gave 91.4% Na salt or PrCOCH₂CN; phenylhydrazone of the ketone, m. 96°. AcCH:CHNMe₂ (5 g.) and 4.5 g. NCCH₂CONH₂ in 50 ml. H₂O refluxed 2 hrs., the mixture cooled, filtered, and the filtrate heated 2 hrs. longer gave 65% (total) 2-hydroxy-3-cyano-6-methylpyridine, m. 278-80°; a 59% yield is obtained when the amino ketone is prepared in situ by treating AcCH:CHCl with aqueous Me₂NH and then following the above procedure. Similarly PrCOCH:CHNMe₂ and NCCH₂CONH₂ gave in 5 hrs. 72% 2-hydroxy-3-cyano-6-propylpyridine, m. 147-8°, while iso-BuCOCH:CHNMe₂ gave 74.8 % 6-iso-Bu homolog, m. 148-9° (from EtOH). To MeMgI from 47 g. MeI in 250 ml. Et₂O was added with good cooling 41 g. AcCH:CHNMe₂, yielding an oil which soon solidified; the mixture was treated after 3 hrs. with 10% HCl and extracted with Et₂O yielding 19.8% AcCH:CHMe, b. 121-3°, d₂₀ 0.8573, n_D²⁰ 1.4390; 2,4-dinitrophenylhydrazone, m. 153-4°. Refluxing 25 g. AcCH:CHNMe₂ and 52 g. MeI 6 hrs., cooling, adding 50 ml. H₂O, heating 0.5 hr., steam distilling the MeI, extracting with Et₂O, and distilling the extract gave 17.5% AcCMe:CHOH, b. 145-8°, m. 72°. AcCH:CHNMe₂ (6 g.) and 9 g. MeI in C₆H₆ refluxed 4 hrs. and the mixture allowed to stand several days gave 33% of a crystalline addition product, C₇H₁₄ONI, decompose 120-2°, yielding with hot H₂O AcCMe:CHOH, identical with the above specimen. In the experiment, the researchers used many compounds, for example, 5-Methylisoxazole (cas: 5765-44-6Safety of 5-Methylisoxazole).

5-Methylisoxazole (cas: 5765-44-6) belongs to isoxazole derivatives. Isoxazoles present in various natural products and synthetic compounds of biological importance like antibacterial, antagonists, antiinflammatory, analgesics, and also show the applications in functional materials. Isoxazole can be synthesised via a variety of methods. Examples include via a 1,3-dipolar cycloaddition of nitrile oxides with alkynes.Safety of 5-Methylisoxazole

Referemce:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

Computational determination of toxicity risks associated with a selection of approved drugs having demonstrated activity against COVID-19 was written by Aminpour, Maral;Delgado, Williams Ernesto Miranda;Wacker, Soren;Noskov, Sergey;Houghton, Michael;Tyrrell, D. Lorne J.;Tuszynski, Jack A.. And the article was included in BMC Pharmacology and Toxicology in 2021.SDS of cas: 1380087-89-7 This article mentions the following:

The emergence and rapid spread of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) in thelate 2019 has caused a devastating global pandemic of the severe pneumonia-like disease coronavirus disease 2019 (COVID-19). Although vaccines have been and are being developed, they are not accessible to everyone and not everyone can receive these vaccines. Also, it typically takes more than 10 years until a new therapeutic agent is approved for usage. Therefore, repurposing of known drugs can lend itself well as a key approach for significantly expediting the development of new therapies for COVID-19. We have incorporated machine learning-based computational tools and in silico models into the drug discovery process to predict Adsorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) profiles of 90 potential drugs for COVID-19 treatment identified from two independent studies mainly with the purpose of mitigating late-phase failures because of inferior pharmacokinetics and toxicity. Here, we summarize the cardiotoxicity and general toxicity profiles of 90 potential drugs for COVID-19 treatment and outline the risks of repurposing and propose a stratification of patients accordingly. We shortlist a total of five compounds based on their non-toxic properties. In summary, this manuscript aims to provide a potentially useful source of essential knowledge on toxicity assessment of 90 compounds for healthcare practitioners and researchers to find off-label alternatives for the treatment for COVID-19. The majority of the mols. discussed in this manuscript have already moved into clin. trials and thus their known pharmacol. and human safety profiles are expected to facilitate a fast track preclin. and clin. assessment for treating COVID-19. In the experiment, the researchers used many compounds, for example, (S)-2-(6-(4-Chlorophenyl)-1-methyl-4H-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide (cas: 1380087-89-7SDS of cas: 1380087-89-7).

(S)-2-(6-(4-Chlorophenyl)-1-methyl-4H-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide (cas: 1380087-89-7) belongs to isoxazole derivatives. Isoxazoles also form the basis for a number of drugs, including the COX-2 inhibitor valdecoxib (Bextra) and a neurotransmitter agonist AMPA. Isoxazoles are potent isosteres of pyridine and have been found to inhibit voltage-gated sodium channels for pain control, for the construction of tetracycline antibiotic derivatives, and as a therapeutic agent for depression.SDS of cas: 1380087-89-7

Referemce:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

The spike-ACE2 binding assay: An in vitro platform for evaluating vaccination efficacy and for screening SARS-CoV-2 inhibitors and neutralizing antibodies was written by Zhang, Shuangzhe;Gao, Chunhui;Das, Tuhin;Luo, Shuhong;Tang, Hao;Yao, Xinyi;Cho, Chih Yun;Lv, Jingqiao;Maravillas, Kino;Jones, Valerie;Chen, Xiaofeng;Huang, Ruopan. And the article was included in Journal of Immunological Methods in 2022.HPLC of Formula: 883944-52-3 This article mentions the following:

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 has become a worldwide pandemic, and there is a pressing need for the rapid development of novel therapeutic strategies. SARS-CoV-2 viral entry is mediated by interaction between the receptor binding domain (RBD) of the SARS-CoV-2 Spike protein and host cellular receptor, human angiotensin converting enzyme 2 (ACE2). The lack of a high throughput screening (HTS) platform for candidate drug screening means that no targeted COVID-19 treatments have been developed to date. To overcome this limitation, we developed a novel, rapid, simple, and HTS binding assay platform to screen potential inhibitors of the RBD-ACE2 complex. Three “neutralizing” mouse monoclonal antibodies capable of blocking the RBD-ACE2 interaction were identified using our binding assay and pseudovirus neutralization assay followed by further validation with the Focus Reduction Neutralization Test (FRNT), which analyzes the neutralization capacity of samples in the presence of live SARS-CoV-2. Furthermore, the consistency of our binding assay and FRNT results (R² = 0.68) was demonstrated by patients′ serum, of which were COVID-19 pos. (n = 34) and COVID-19 neg. (n = 76). Several small mols. selected for their potential to inhibit the Spike-ACE2 complex in silico were also confirmed with the binding assay. In addition, we have evaluated vaccine efficacy using binding assay platform and validated through pseudovirus neutralization assay. The correlation between binding assay & psuedovirus assay of the post vaccinated serum showed well correlated (R² = 0.09). Moreover, our binding assay platform successfully validated different Spike RBD mutants. These results indicate that our binding assay can be used as a platform for in vitro screening of small mols. and monoclonal antibodies, and high-throughput assessment of antibody levels after vaccination. When conducting drug screening, computer virtual screening lacks actual basis, construction of pseudoviruses is relatively complicated, and even FRNT requires a P3 laboratory There are few methods to determine the competitiveness of the target drug and SRBD or ACE2. Our binding assay can fill this gap and accelerate the process and efficiency of COVID-19 drug screening. In the experiment, the researchers used many compounds, for example, N-(4-(4-Methylpiperazin-1-yl)benzyl)isoxazole-5-carboxamide (cas: 883944-52-3HPLC of Formula: 883944-52-3).

N-(4-(4-Methylpiperazin-1-yl)benzyl)isoxazole-5-carboxamide (cas: 883944-52-3) belongs to isoxazole derivatives. Isoxazoles also form the basis for a number of drugs, including the COX-2 inhibitor valdecoxib (Bextra) and a neurotransmitter agonist AMPA. Isoxazoles are potent isosteres of pyridine and have been found to inhibit voltage-gated sodium channels for pain control, for the construction of tetracycline antibiotic derivatives, and as a therapeutic agent for depression.HPLC of Formula: 883944-52-3

Referemce:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

Adjuvant electroconvulsive therapy with antipsychotics is associated with improvement in auditory mismatch negativity in schizophrenia was written by Liu, Yi;Jia, Li-na;Wu, Han;Jiang, Wei;Wang, Qian;Wang, Dan;Xiong, Yan-bing;Ren, Yan-ping;Ma, Xin;Tang, Yi-lang. And the article was included in Psychiatry Research in 2022.Electric Literature of C23H27FN4O3 This article mentions the following:

Schizophrenia is a common mental disorder characterized by pos. (psychotic) symptoms, neg. symptoms, and cognitive deficits. We found electroconvulsive therapy (ECT) treatment was associated with improvement in clin. symptoms, cognitive function, as well as auditory Mismatch negativity (MMN). The changes in MMN were associated with the improvement in cognition. MMN may be a biomarker of the effects of ECT on cognitive function in patients with SZ. To our knowledge, the effects of ECT on MMN in patients with SZ have not been reported. Therefore, the present study was set to investigate the effects of ECT on auditory MMN in patients with SZ and explore the relations between MMN, psychotic symptoms, and cognitive function before and after ECT treatment. We used the bifrontal electrode placement and all patients received 8 sessions. Our hypotheses were: (1)Compared with age-and sex-matched healthy controls, patients with SZ were worse in MMN and cognitive function; (2) ECT treatment would lead to improvement in clin. symptoms, cognitive function, and MMN amplitude; (3) There were significant correlations between the changes in MMN and changes in clin. symptoms and cognitive measurements, In the experiment, the researchers used many compounds, for example, 3-(2-(4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one (cas: 144598-75-4Electric Literature of C23H27FN4O3).

3-(2-(4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one (cas: 144598-75-4) belongs to isoxazole derivatives. Isoxazole are described as inhibitors of acetylcholinesterase (AChE). Isoxazole ligands bind to and inhibit the Sxc- antiporter. Fe(CO)5 efficiently cleaves the N–O bond of fused isoxazolo-1,4-quinones to give the corresponding imines.All the common reducing reagents failed to open the isoxazole ring.Electric Literature of C23H27FN4O3

Referemce:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

Stiripentol inhibits spike-and-wave discharges in animal models of absence seizures: A new mechanism of action involving T-type calcium channels was written by Riban, Veronique;Heulard, Isabelle;Reversat, Lucie;Si Hocine, Hakim;Verleye, Marc. And the article was included in Epilepsia in 2022.SDS of cas: 85118-33-8 This article mentions the following:

Stiripentol (STP; Diacomit) is an antiepileptic drug indicated for Dravet syndrome that has been identified as a γ-aminobutyric acid (GABAergic) pos. allosteric modulator. Dravet syndrome is characterized by multiple seizure types: generalized tonic-clonic, focal, myoclonic, and absence seizures. In addition to its antiepileptic effects on tonic-clonic seizures, STP has also been reported to reduce the frequency of atypical absence seizures in patients. Our study focused on STP potential effects on absence seizures, to better characterize its full spectrum of mechanisms of action. STP effects on absence seizures were quantified by electroencephalog. recording in two animal models: rats treated with a low dose of pentylenetetrazol (20 mg/kg i.p.) and rats from the WAG/Rij strain. In addition, we characterized STP effects on T-type calcium channel activity. Peak currents were recorded with manual patch clamp on cells transfected with cDNA encoding for the human isoform for Cav3.1, Cav3.2, and Cav3.3. STP administered before pentylenetetrazol almost completely abolished the generation of spike-and-wave discharges (SWDs) at the dose of 300 mg/kg. At this dose, STP also statistically significantly decreased SWD cumulated duration and number in WAG/Rij rats. Its antiepileptic effect was maintained in WAG/Rij rats, whose seizures were aggravated by the GABA agonist THIP (gaboxadol hydrochloride). Furthermore, electrophysiol. recordings showed that STP inhibits T-type calcium channel peak activity, with a higher specificity for the Cav3.3 subtype. In addition to its previously characterized anticonvulsive properties, these data highlight a new mechanism of action of STP on abnormal thalamocortical activity. This strong antiabsence effect on seizures is correlated with an inhibition of T-type calcium channels. This new mechanism of action could be implicated in the specificity of STP therapeutic effects in Dravet syndrome. In the experiment, the researchers used many compounds, for example, 4,5,6,7-Tetrahydroisoxazolo[5,4-c]pyridin-3(2H)-one hydrochloride (cas: 85118-33-8SDS of cas: 85118-33-8).

4,5,6,7-Tetrahydroisoxazolo[5,4-c]pyridin-3(2H)-one hydrochloride (cas: 85118-33-8) belongs to isoxazole derivatives. Isoxazoles are aromatic heterocycles containing an N–O bond. The weakness of this bond allows the ring opening of these heterocycles under reductive conditions. The electrophilic cyclization of various 2-alkynone O-methyl oximes with a wide range of substrates such as ICl, I2, Br2, PhSeBr, etc. provides a variety of 3,4,5-trisubstituted isoxazoles in good to excellent yields.SDS of cas: 85118-33-8

Referemce:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

Asymmetric dimethylarginine in psychiatric disorders was written by Braun, Daniel;Schlossmann, Jens;Haen, Ekkehard. And the article was included in Psychiatry Research in 2021.Synthetic Route of C23H27FN4O3 This article mentions the following:

Serum concentrations of asym. dimethylarginine (ADMA) in patients with schizophrenia, schizoaffective disorder, bipolar disorder, and depression were determined and compared to serum concentrations in healthy individuals. In all psychiatric diseases investigated, the ADMA concentration was elevated compared to the control group. Patients with recurrent depressive disorder had higher ADMA levels than patients with only one depressive episode. No differences between women and men were found. The elevated ADMA levels suggest that ADMA is involved in the pathophysiol. of psychiatric diseases. In the experiment, the researchers used many compounds, for example, 3-(2-(4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one (cas: 144598-75-4Synthetic Route of C23H27FN4O3).

3-(2-(4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one (cas: 144598-75-4) belongs to isoxazole derivatives. Isoxazole rings are found in some natural products, such as ibotenic acid and muscimol. Some alternative routes for the synthesis of isoxazoles have also been developed and reported. The 2-benzoyl-2-halo-2H-azirines provide 4-haloisoxazoles in good yields after heating in toluene at reflux temperature.Synthetic Route of C23H27FN4O3

Referemce:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

Synthesis, Biological Evaluation, and Structure-Activity Relationships for 5-[(E)-2-Arylethenyl]-3-isoxazolecarboxylic Acid Alkyl Ester Derivatives as Valuable Antitubercular Chemotypes was written by Pieroni, Marco;Lilienkampf, Annamaria;Wan, Baojie;Wang, Yuehong;Franzblau, Scott G.;Kozikowski, Alan P.. And the article was included in Journal of Medicinal Chemistry in 2009.Synthetic Route of C4H5NO This article mentions the following:

Tuberculosis (TB), mostly caused by Mycobacterium tuberculosis (Mtb), is one of the leading causes of death from infectious disease worldwide. Its coinfection with HIV and the emergence of multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) strains have further worsened the TB pandemic. Despite its global impact, TB is considered a neglected disease and no new anti-TB therapeutics have been introduced over the last four decades. The nonreplicating persistent form of TB (NRP-TB) is responsible for the length of the treatment and is the putative cause of treatment failure. Therefore, new anti-TB agents, which are active against both the replicating form of Mtb (R-TB) and NRP-TB, are urgently needed. The synthesis and structure-activity relationships (SAR) of a series of 5-[(E)-2-arylethenyl]-3-isoxazolecarboxylic acid alkyl esters e.g. I, as potent anti-TB agents are reported. Several compounds had submicromolar min. inhibitory concentrations (MIC) against R-TB and were active against NRP-TB in the low micromolar range, thus representing attractive lead compounds for the possible development of new anti-TB agents. In the experiment, the researchers used many compounds, for example, 5-Methylisoxazole (cas: 5765-44-6Synthetic Route of C4H5NO).

5-Methylisoxazole (cas: 5765-44-6) belongs to isoxazole derivatives. Isoxazole are described as inhibitors of acetylcholinesterase (AChE). Isoxazole ligands bind to and inhibit the Sxc- antiporter. Isoxazoles are potent isosteres of pyridine and have been found to inhibit voltage-gated sodium channels for pain control, for the construction of tetracycline antibiotic derivatives, and as a therapeutic agent for depression.Synthetic Route of C4H5NO

Referemce:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

Preparation and reactivity of acetoacetonitrile dianion was written by Vinick, Fredric J.;Pan, Yolanda;Gschwend, Heinz W.. And the article was included in Tetrahedron Letters in 1978.Application In Synthesis of 5-Methylisoxazole This article mentions the following:

The title dianion (I) was prepared by treating 5-methylisoxazole (II) with 2 equiv LiN(CHMe₂)₂ in THF at -10°. I underwent alkylation by alkyl halides RX to give unstable RCH₂COCH₂CN; immediate NaBH₄ reduction of the products gave RCH₂CH(OH)CH₂CN (R = allyl, Pr, PhCH₂) in 49-52% overall yield from II. I with RCOR¹ (R = H, R¹ = 4-ClC₆H₄; R = R¹ = Ph) gave 44-82% RC(OH)R¹CH₂CH(OH)CH₂CN. I with PhCN gave 24% PhC(NH₂):CHCOCH₂CN. I with RC₆H₄CN (R = 4-MeO, -Cl, 3-Me) gave 62-5% of the corresponding 6-(RC₆H₄)-substituted 2-amino-4(1H)-pyridones. In the experiment, the researchers used many compounds, for example, 5-Methylisoxazole (cas: 5765-44-6Application In Synthesis of 5-Methylisoxazole).

5-Methylisoxazole (cas: 5765-44-6) belongs to isoxazole derivatives. Isoxazoles are aromatic heterocycles containing an N–O bond. Isoxazoles are commonly used as enaminoketone or β-diketone surrogate. The most common methods for N–O bond cleavage in isoxazoles are hydrogenation with palladium or platinum catalysts or with Raney Ni. Recent developments have shown that Mo(CO)6 efficiently cleaves the N–O bond in isoxazoles.Application In Synthesis of 5-Methylisoxazole

Referemce:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

Soil metabolism of the herbicide isoxaben in winter wheat crops was written by Rouchaud, Jean;Gustin, Fabrice;Callens, Dany;Van Himme, Michel;Bulcke, Robert. And the article was included in Journal of Agricultural and Food Chemistry in 1993.HPLC of Formula: 14678-05-8 This article mentions the following:

Winter wheat fields were treated with the herbicide isoxaben after sowing. Trials were made in 1990-1991 and 1991-1992. The main isoxaben soil metabolite was demethoxyisoxaben (N-[3-(1-ethyl-1-methylpropyl)isoxazol-5-yl]-2-hydroxy-6-methoxybenzamide), i.e., the monodemethoxylation product of isoxaben. 5-Isoxazolone (3-(1-ethyl-1-methylpropyl)isoxazolin-5-one) was the second main isoxaben metabolite. When 5-aminoisoxazole (5-amino-3-(1-ethyl-1-methylpropyl)isoxazole) was detected in soil, it always was at very low concentrations It never accumulated in soil; 4 mo before winter wheat harvest, it could not be detected in soil. Benzamides 2,6-dimethoxybenzamide and 2-hydroxy-6-methoxybenzamide and 2,6-dimethoxybenzoic acid also were detected in soil. Organic fertilizer treatments increased isoxaben soil persistence. At the crop’s end, their effects, however, progressively disappeared, the soil residues of isoxaben and of its metabolites becoming very low and similar in the organic fertilizer treated and untreated plots. 5-Aminoisoxazole was not detected. Thus, isoxaben was soil-metabolized into nontoxic products, unable to generate toxic ones, during the wheat crops whose soil had been treated or not treated with organic fertilizers. In the experiment, the researchers used many compounds, for example, Isoxazol-5-amine (cas: 14678-05-8HPLC of Formula: 14678-05-8).

Isoxazol-5-amine (cas: 14678-05-8) belongs to isoxazole derivatives.Synthetically, isoxazoles serve as valuable precursors for the construction of diverse molecules, including many natural products. The electrophilic cyclization of various 2-alkynone O-methyl oximes with a wide range of substrates such as ICl, I2, Br2, PhSeBr, etc. provides a variety of 3,4,5-trisubstituted isoxazoles in good to excellent yields.HPLC of Formula: 14678-05-8

Referemce:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

β-Methylisoxazole was written by Pino, Piero;Ercoli, Raffaele. And the article was included in Rend. ist. lombardo sci, Pt. I, Classe sci. mat. e nat. in 1955.Product Details of 5765-44-6 This article mentions the following:

The chemical behavior of β-methylisoxazole (I) is similar to that of the α-isomer (II). I is somewhat more stable towards halogenation but is less stable towards alkali than II or the γ-isomer (III) but is more stable than isoxazole. Ring opening occurs by the same mechanism as for I (C.A. 49, 6228i). The following rate constants for the ring opening reaction are (compound and k × 10⁴ l. mole^-1 sec.^-1 given). I 3.1, II 1.4, III 0.1, IV 4.5. Thus from I and β-phenylisoxazole can be prepared NCCHMeCHO and NCCHPhCHO, resp. In the experiment, the researchers used many compounds, for example, 5-Methylisoxazole (cas: 5765-44-6Product Details of 5765-44-6).

5-Methylisoxazole (cas: 5765-44-6) belongs to isoxazole derivatives. Isoxazole are described as inhibitors of acetylcholinesterase (AChE). Isoxazole ligands bind to and inhibit the Sxc- antiporter. Fe(CO)5 efficiently cleaves the N–O bond of fused isoxazolo-1,4-quinones to give the corresponding imines.All the common reducing reagents failed to open the isoxazole ring.Product Details of 5765-44-6

Referemce:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem